Takeda Pharmaceutical Co., Ltd./ US8740602052 /
| 2018-12-21 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.5900USD | - | 7.86 mill. Turnover: - |
-Bid Size: - | -Ask Size: - | 48.82 bill.USD | - | - |
Assets
|
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 536,801 | 1.32 mill. | 1.39 mill. | 1.45 mill. | 1.58 mill. | ||||||
| Intangible Assets | 1.01 mill. | 4.86 mill. | 4.17 mill. | 3.91 mill. | 3.82 mill. | ||||||
| Long-Term Investments | 107,949 | 114,658 | 262,121 | 235,882 | 96,579 | ||||||
| Fixed Assets | - | - | - | - | 10.58 mill. | ||||||
| Inventories | 212,944 | 986,744 | 759,599 | 753,881 | 853,167 | ||||||
| Accounts Receivable | 420,247 | 741,907 | 757,005 | 783,091 | 696,644 | ||||||
| Cash and Cash Equivalents | 294,522 | 702,093 | 637,614 | 966,222 | 849,695 | ||||||
| Current Assets | 1.08 mill. | 3.05 mill. | 2.47 mill. | 2.71 mill. | 2.59 mill. | ||||||
| Total Assets | 4.11 mill. | 13.87 mill. | 12.82 mill. | 12.91 mill. | 13.18 mill. | ||||||
Liabilities
|
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 240,259 | 327,394 | 318,816 | 343,838 | 516,297 | ||||||
| Long-term debt | - | - | - | - | 4.14 mill. | ||||||
| Liabilities to Banks | 18 | 984,946 | 586,817 | 22,153 | - | ||||||
| Provisions | 186,461 | 1.02 mill. | 930,490 | 726,803 | 947,212 | ||||||
| Liabilities | 2.09 mill. | 8.71 mill. | 8.09 mill. | 7.74 mill. | 7.49 mill. | ||||||
| Share Capital | 77,914 | 1.64 mill. | 1.67 mill. | 1.67 mill. | - | ||||||
| Total Equity | 2.02 mill. | 5.16 mill. | 4.73 mill. | 5.18 mill. | 5.68 mill. | ||||||
| Minority Interests | 19,985 | 4,006 | 4,003 | 4,140 | 504 | ||||||
| Total liabilities equity | 4.11 mill. | 13.87 mill. | 12.82 mill. | 12.91 mill. | 13.18 mill. | ||||||
Income Statement
|
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1.77 mill. | 2.1 mill. | 3.29 mill. | 3.2 mill. | 3.57 mill. | ||||||
| Depreciation (total) | 122,131 | 203,372 | 455,420 | 421,864 | 472,915 | ||||||
| Operating Result | 241,789 | 204,969 | 100,408 | 509,269 | 460,844 | ||||||
| Interest Income | 7,615 | -66,446 | -137,175 | -143,110 | -142,907 | ||||||
| Income Before Taxes | 217,205 | 94,896 | -60,754 | 366,235 | - | ||||||
| Income Taxes | 30,497 | -14,118 | -105,044 | -9,936 | 72,405 | ||||||
| Minority Interests Profit | 178 | 112 | -49 | -166 | -107 | ||||||
| Net Income | 186,886 | 109,126 | 44,241 | 376,005 | 230,059 | ||||||
Per Share
Cash Flow
|
2018 - in mill. JPY |
2019 - in mill. JPY |
2020 IFRS in mill. JPY |
2021 IFRS in mill. JPY |
2022 IFRS in mill. JPY |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 377,854 | 328,479 | 669,752 | 1.01 mill. | 1.12 mill. | ||||||
| Cash Flow from Investing Activities | -93,342 | -2.84 mill. | 292,119 | 393,530 | -198,125 | ||||||
| Cash Flow from Financing | -326,226 | 2.95 mill. | -1.01 mill. | -1.09 mill. | -1.07 mill. | ||||||
| Decrease / Increase in Cash | -41,714 | 439,018 | -43,342 | 316,107 | - | ||||||
| Employees | 27,230 | 49,578 | 47,495 | 47,099 | 47,000 | ||||||
